Grants and Contributions

The specific objective of this funding opportunity is:

• To provide entry for trainees to the SPA 2024 program to trainees interested in the area of: Ageism in Health Research, Delivery, and Outcomes in Older Adults.

• The CIHR HIV/AIDS and STBBI Research Initiative (RI), under the leadership of the CIHR Institute of Infection and Immunity (CIHR-III), is responsible for funding research on human immunodeficiency virus (HIV), hepatitis B (HBV) and C (HCV), chlamydia, gonorrhea, syphilis, and human papilloma virus (HPV). This funding is provided across all CIHR research themes: biomedical research, clinical research, health services research and social, cultural, environmental and population health research.
• Research that focuses on key populations disproportionately affected by HIV/AIDS and STBBI is highly encouraged.
• In alignment with CIHR's commitment to equity, diversity and inclusion (EDI) in the research system, the RI champions EDI as a means to support excellence in research, training and knowledge mobilization. Therefore, we encourage people from diverse backgrounds, including groups underrepresented in science such as women and racial and ethnic minorities, to apply.
• This priority announcement will prioritize funding for research on HIV and/or STBBI aligned with the CIHR HIV/AIDS Research Initiative: Strategic Plan (2022-2027) in the following research areas:
o Improving health equity by advancing research to understand and address determinants of health, new models of care, or sexual and reproductive health for people living with or at risk of HIV/AIDS and STBBI; or
o Accelerating discovery and innovation by advancing research on innovative technologies for testing and surveillance, interactions among infections and co-morbidities, or design and development of next-generation interventions.
• Should there be no eligible applications relevant to the research areas identified above, applications must be in alignment with the strategic directions of the CIHR HIV/AIDS Research Initiative: Strategic Plan (2022-2027) to be funded.

Flood made tremendous contributions towards advancing the field of health services and policy research in Canada, building a community of world-class researchers, and designing innovative new programs that foster evidence-informed decision making and improved health and health care for Canadians

• The CIHR Institute of Musculoskeletal Health and Arthritis (CIHR-IMHA) will fund applications that are determined relevant to its mandate and research priority areas as described below:
• IMHA mandate areas
o Pain
o Oral Health

• The CIHR Institute of Nutrition, Metabolism and Diabetes (CIHR-INMD) will provide funding for applications in which the objectives and aims are determined to be largely and directly relevant to the INMD mandate as described below:
o CIHR-INMD supports research to enhance health in relation to diet, digestion, excretion, and metabolism; and to address causes, prevention, screening, diagnosis, treatment, support systems, and palliation for a wide range of conditions and problems associated with hormone, digestive system, kidney, and liver.
• These grants afford principal investigators an opportunity to resubmit their research proposal without the loss of momentum, staff or trainees.

• The CIHR Institute of Nutrition, Metabolism and Diabetes (CIHR-INMD) will provide funding for applications in which the objectives and aims are determined to be largely and directly relevant to the INMD mandate as described below:
o CIHR-INMD supports research to enhance health in relation to diet, digestion, excretion, and metabolism; and to address causes, prevention, screening, diagnosis, treatment, support systems, and palliation for a wide range of conditions and problems associated with hormone, digestive system, kidney, and liver.
• These grants afford principal investigators an opportunity to resubmit their research proposal without the loss of momentum, staff or trainees.

Patient-Oriented Research (POR), which is foundational to evidence-informed health care, refers to a continuum of research that engages patients, including People with Lived and Living Experience (PWLLE), as partners throughout the research process, focusses on patient-identified priorities, and improves patient outcomes. This research, conducted by multidisciplinary teams in partnership with relevant stakeholders, aims to apply the knowledge generated to improve health outcomes for Canadians.

The Strategy for Patient-Oriented Research (SPOR) is a national coalition of federal, provincial and territorial partners (patients and informal caregivers, health authorities, academic health centres, charities, philanthropic organizations, private sector, etc.) dedicated to the integration of patient-oriented research into care.

SPOR funded research requires the inclusion of a diversity of patients (including PWLLE) in health research in a culturally safe manner, while considering accessibility and equity within the patient partners they include in their patient-oriented research.

The vision for SPOR is that Canada will demonstrably improve health outcomes and enhance the health care experience for patients through the integration of evidence at all levels of the health care system.

CIHR is committed to leverage the power of research to accelerate global health equity for all. The CIHR Framework for Action on Global Health Research 2021-2026 recognizes that CIHR must work globally because today’s most pressing health problems, and many of the most effective strategies to prevent, contain, and address them, are global. In alignment with this Framework, this priority announcement aims to grow global health research capacity and excellence.

Funding will be provided for applications that have a primary focus on global health research (as per CIHR’s definition) and that are relevant to one of the mandates below:
o Centre for Research on Pandemic Preparedness and Health Emergencies
o Institute of Gender and Health
o Institute of Population and Public Health

For the purpose of this PA, sport is defined as “Activities that develop specific skills, and that are organized around competition and governed by rules” and will contribute to the National Women's Health Research Initiative (NWHRI) which is advancing a coordinated research program that addresses under-researched and high-priority areas of women's health and will ensure new evidence improves women's and gender-diverse people's care and health outcomes.

This award will be given annually to the highest-ranking Early Career Researchers in the Project competition that fall within the CIHR Institute of Cancer Research (CIHR-ICR) mandate:
o ICR has a mandate to support research that reduces the burden of cancer on individuals and families through prevention strategies, screening, diagnosis, effective treatments, psycho-social support systems, and palliation.